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Abstract
Background: ADP-ribosylation is an enzyme-catalyzed posttranslational protein modification in which
mono(ADP-ribosyl)transferases (mARTs) and poly(ADP-ribosyl)transferases (pARTs) transfer the ADP-
ribose moiety from NAD onto specific amino acid side chains and/or ADP-ribose units on target proteins.
Results: Using a combination of database search tools we identified the genes encoding recognizable
pART domains in the public genome databases. In humans, the pART family encompasses 17 members.
For 16 of these genes, an orthologue exists also in the mouse, rat, and pufferfish. Based on the degree of
amino acid sequence similarity in the catalytic domain, conserved intron positions, and fused protein
domains, pARTs can be divided into five major subgroups. All six members of groups 1 and 2 contain the
H-Y-E trias of amino acid residues found also in the active sites of Diphtheria toxin and Pseudomonas
exotoxin A, while the eleven members of groups 3 – 5 carry variations of this motif. The pART catalytic
domain is found associated in Lego-like fashion with a variety of domains, including nucleic acid-binding,
protein-protein interaction, and ubiquitylation domains. Some of these domain associations appear to be
very ancient since they are observed also in insects, fungi, amoebae, and plants. The recently completed
genome of the pufferfish T. nigroviridis contains recognizable orthologues for all pARTs except for pART7.
The nearly completed albeit still fragmentary chicken genome contains recognizable orthologues for
twelve pARTs. Simpler eucaryotes generally contain fewer pARTs: two in the fly D. melanogaster, three
each in the mosquito A. gambiae, the nematode C. elegans, and the ascomycete microfungus G. zeae, six in
the amoeba E. histolytica, nine in the slime mold D. discoideum, and ten in the cress plant A. thaliana.
GenBank contains two pART homologues from the large double stranded DNA viruses Chilo iridescent
virus and Bacteriophage Aeh1 and only a single entry (from V. cholerae) showing recognizable homology
to the pART-like catalytic domains of Diphtheria toxin and Pseudomonas exotoxin A.
Conclusion: The pART family, which encompasses 17 members in the human and 16 members in the
mouse, can be divided into five subgroups on the basis of sequence similarity, phylogeny, conserved intron
positions, and patterns of genetically fused protein domains.
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Background
ADP-ribosylation is a posttranslational protein modifica-
tion in which the ADP-ribose moiety is transferred from
NAD onto specific amino acid side chains of target pro-
teins [1-4]. ADP-ribosylation was originally discovered as
the pathogenic principle of Diphtheria toxin, a multido-
main secreted protein which inactivates elongation factor
2 by ADP-ribosylation after translocation into eucaryotic
cells [5]. Subsequently, numerous other bacterial toxins
were shown to ADP-ribosylate target proteins in host cells.
Moreover, endogenous toxin-like ADP-ribosylating
enzyme activities were detected in eucaryotic cells. Several
of these enzymes were purified to homogeneity,
sequenced, expressed as recombinant proteins, and
crystallized.
Sequence and structural analyses revealed the existence of
two distinct families of toxin-related ADP-ribosyltrans-
ferases in mammals [6,7]: The RT6 family of GPI-
anchored and secretory mono-(ADP-ribosyl)transferases
(mARTs) catalyzes mono-ADP-ribosylation of cell surface
and secretory proteins [8]. The PARP family of nuclear and
cytoplasmic poly(ADP-ribosyl)transferases (pARTs) cata-
lyzes poly-ADP-ribosylation of nuclear and cytosolic pro-
teins [9-12]. While mARTs have been implicated to
mediate signalling functions of extracellular NAD, pARTs
have been shown to play important roles in DNA repair
and maintenance of genome integrity [8,9,12].
In this paper we use the term pART (poly ADP-ribosyl-
transferase) rather than the more established term PARP
(poly-ADP-ribosyl-polymerase) for various reasons.
Firstly, to emphasize the structural and functional similar-
ities of the poly- and mono-ADP-rib syltransferase sub-
families. Secondly, with respect to the biochemical
classficiation of enzymes the term transferase is more
appropriate than polymerase: ADP-riboslytransferases
belong to the family of glycosyltransferases; the term
polymerase is more commonly used for template-depend-
ent DNA or RNA synthesizing enyzmes. Thirdly, use of the
term PARP would have confounded comparison of our
results with those of the recent review by Ame et al. [11],
who used the term PARP and a numbering system without
regard to structural similarities among gene family
members.
The 3D-structures of rat ART.2 (PDB accession number
1og3), chicken PARP-1 (1a26, 3pax), mouse PARP-2
(1gs0), and numerous ADP-ribosylating toxins uncovered
a common NAD binding fold with a conserved core of five
β strands arranged in two abutting β sheets [13-19]. These
two β sheets form the upper and lower jaws of a Pacman-
like active site crevice (Figure 1). Remarkably, only a sin-
gle amino acid residue, the catalytic glutamic acid residue
at the front edge of the fifth conserved β-strand, is strictly
conserved in all known 3D structures of enzymatically
active mARTs and pARTs. In a seminal study, Collier and
co-workers pinpointed the corresponding glutamic acid
residue in PARP-1 (before its 3D structure was solved) on
the basis of barely detectable sequence similarity to Diph-
theria toxin [20,21]. More recently, the 3D structures of
anthrax lethal factor, VIP2, and iota toxin have been dis-
covered to harbour ART-domains that lack a correspond-
ing glutamic acid residue and may represent inactivated
enzymes [16,22,23].
Comparative structure and amino acid sequence analyses
revealed that PARP-1 and PARP-2 share additional sec-
ondary structure and conserved amino acids with Diph-
theria toxin and Pseudomonas exotoxin A, which
evidently are not conserved in other mARTs (Fig. 1) [6,7].
These additional elements include a sixth β strand, an
alpha helix between β strands 2 and 3, and a trias of
amino acids, the so-called H-Y-E motif, encompassing a
histidine resdiue in β strand 1, a tyrosine residue in β
strand 3 and the catalytic glutamic acid residue at the front
edge of β strand 5. These features, highlighted in the 3D
structures of PARP-1 and Diphtheria toxin in Figure 1,
clearly distinguish the structures of PARP-1, PARP-2, and
DT/ETA from those of a second major ART subfamily that
includes rat ART2 and the Bacillus cereus VIP2 toxin. Dis-
tinguishing features of the ART2/VIP2 subfamliy include a
seventh β strand that displaces β strand 6, three conserved
alpha helices preceding β strand 1, and an R-S-E trias of
amino acid residues in place of the H-Y-E motif of PARP-
1 and DT. Interestingly, the recently reported 3D-structure
of a prototype member of the family of tRNA:NAD 2'
phosphotransferases (TpT) [24] revealed a striking resem-
blance to the structures of the PARP-1/DT subfamily
rather than to those of the ART2/VIP subfamily, including
the sixth β strand, the alpha helix between β strands 2 and
3, and a variant H-Y-E motif (H-H-V). These enzymes cat-
alyze removal of a splice junction 2' phosphate from
ligated tRNA. This reaction resembles the reaction cata-
lyzed by ARTs but yields ADP-ribose 1"-2" cyclic phos-
phate rather than ADP-ribosylated proteins [25].
The remarkable degree of plasticity of ART amino acid
sequences poses a challenging problem for genome data
base mining [7] and even the most sensitive database
search programs fail to connect all known members of the
ART gene family. Notwithstanding, the results of such in
silico  analyses can provide important insight into the
structural and phylogenetic relationship of ART sub-
families. We have previously demonstrated that the
known members of the mART gene family in the human
and mouse could be faithfully connected with many
known bacterial ADP-ribosylating toxins, but not with
pARTs or Diphtheria toxin [26,27]. These analyses also
pointed out the presence of mART-encoding genes in theBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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Schematic illustration of the distinguishing structural features of the PARP-1/DT vs. the ART2/VIP2 subfamilies of ADP-ribosyl- transferases Figure 1
Schematic illustration of the distinguishing structural features of the PARP-1/DT vs. the ART2/VIP2 sub-
families of ADP-ribosyltransferases. Two abutting sheets of anti-parallel β strands form the upper and lower jaws of a 
Pacman-like NAD-binding crevice in all known structures of ADP-ribosyltransferases. The distinguishing structural features of 
the PARP/DT and ART2/VIP2 subfamilies are depicted schematically on top and are highlighted in the structures of chicken 
PARP-1 (3pax), diphtheria toxin (DT) (1tox), an archael tRNA:NAD 2'-phosphotransferase (TpT) (1wfx), rat ART2 (1og3) and 
B. cereus VIP2 toxin (1qs2) below. The structures are depicted from the "front view" with a full view of the ligands bound in the 
active site crevice. The ligands NAD and 3MB are colored cyan and are depicted as stick models. The central four β-strands 
(from top to bottom: β 5, β 2, β 1, β 3, colored orange) are conserved in all mARTs and pARTs. The β strands at the edges of 
the respective sheets (β 4 and β 6, colored pink) show greater structural variation than the central β strands. The H-Y-E motif 
residues are depicted in red and their side chains are shown as sticks. The glutamic acid residue at the front edge of β 5 is the 
critical catalytic residue in both diphtheria toxin and PARP-1 – a corresponding glutamic acid residue is observed also in the 3D 
structures of rat ART2 and numerous bacterial mARTs. Diphtheria toxin (1tox), pseudomonas exotoxin A (1aer), PARP-1 
(3pax), and PARP-2 (1gs0) share the following structural features which are not conserved in either rat ART2 (1og3) or most 
other bacterial mARTs: the orientation of β 6, the alpha helix between β 2 and β 3 (colored yellow) and the conserved histi-
dine and tyrosine amino acid residues in β 1 and β 3. The loop between β 4 and β 5 (colored magenta) is thought to play a role 
in the recognition of target proteins and ADP-ribose polymers. Distinguishing features of ART2, VIP2, iota toxin (1gir), and the 
C3 exoenzymes (1g24, 1ojz) include three conserved alpha helices upstream of β strand 1, a seventh β strand that displaces β 
strand 6 and an R-S-E- motif instead of the H-Y-E motif of PARP-1 and DT. (Note that the depicted ART2 structure carries a 
site directed mutation of the catalytic glutamic acid residue E189I). The recently determined 3D structure of the tRNA:NAD 
2'-phosphotransferase (1wfx) bears striking resemblance to that of DT and PARP-1 and carries an H-H-V variant of the H-Y-E 
motif. Note that the structure of the diphtheria toxin catalytic domain shown here in complex with NAD is truncated C-termi-
nally at the proteolytic cleavage site that separates this domain from the translocation domain. The PARP-1 catalytic domain 
shown here is truncated N-terminally at the position of the phase 0 intron that separates this domain from a neighboring heli-
cal domain. The TpT catalytic domain is truncated N-terminally at the point of fusion to a winged-helix domain.
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genomes of many but not all other model organisms. Of
note, no mART-encoding genes could be detected in
plants, fungi, or archaea. Here we provide an in depth
analysis of the pART gene family.
Results and discussion
Identification of human and mouse pART family members 
in the EST database
The human and mouse pART gene family members were
identified using a combination of data base search tools.
The human and mouse EST databases as well as the non-
redundant GenBank database (nr) were screened with
tBLASTn using as queries the amino acid sequences of the
catalytic domains of the known and newly identified
pART family members. Whenever possible, the full coding
sequence of the catalytic domain and of the adjacent
regions was assembled using the sequences of published
cDNAs and overlapping ESTs. Screening of the EST and nr
databases was initiated in 1997 and was repeated in regu-
lar intervals. The coding sequences were extended when
suitable new sequences became available. When the
sequences of the human, mouse and rat genomes were
published in 2000, 2001, and 2004, respectively, the EST
database searches were complemented with correspond-
ing tBLASTn and BLASTn searches of the genome
sequences [28-30]. Thereby, 17 pART family members
were identified in the human. These genes were desig-
nated pART1-pART17. Numbering reflects the degree of
amino acid sequence similarity to PARP-1 (= pART1) and
the degree of similarity within each of the pART sub-
groups. An orthologue for each of these genes was
detected in the mouse and in the rat, with the sole excep-
tion of pART7.
A complete list of human pART family members, includ-
ing the common names and aliases of known genes, is
presented in Figure 2. Based on the degree of amino acid
sequence similarities, conserved intron positions, and
fused protein domains, the mammalian pART family can
be divided into five major subgroups. Group 1 (pART1-
pART4) contains PARP and its closest relatives, PARP-2,
PARP-3 and VPARP. Group 2 (pART5, pART6) contains
tankyrase 1 and tankyrase 2. Group 3 (pART7-pART10)
contains four proteins including the recently described B-
Aggressive Lymphoma Protein (BAL = pART9) [31] and a
myc-interacting protein with PARP activity (PARP-10)
[32]. Group 4 (pART11-pART14) contains four proteins
including the recently described Zinc-finger Antiviral Pro-
tein (ZAP = pART13) [33] and TCDD-inducible PARP
(TiPARP) [34]. Group 5 (pART15-pART17) contains three
proteins of unknown function.
The steady growth in the number of matching ESTs
obtained for each of the human pART gene family mem-
bers over the past 6 years is illustrated in additional file 1
("Representation of pART gene transcripts in the database
of expressed sequence tags"). By October 2004, each
human pART except pART7 was represented by more than
100 ESTs. Interestingly, each pART except pART7 is repre-
sented by more ESTs than poly (ADP-ribose) glycohydro-
lase (PARG), the single known enzyme capable of
removing poly-ADP-ribose from pART target proteins.
The large number of ESTs corresponds to a large variety of
tissues found to contain pART ESTs and presumably
reflects an ubiquitous pattern of gene expression, i.e. akin
to that of the house keeping enzymes hypoxanthine-gua-
nine phosphoribosyltransferase (HPRT) and glyceralde-
hyde-3-phosphate dehydrogenase (GAPD). For
comparison, the members of the mART gene family
(ART1-ART5), which exhibit highly restricted patterns of
expression, are each represented by much fewer ESTs than
the pARTs. As of January 2005, the mammalian gene col-
lection http://mgc.nci.nih.gov contains annotated full-
length cDNA sequences for 10 of the 17 human pARTs
and for 12 of 16 mouse pARTs (Fig. 2).
Chromosomal localizations and exon/intron structures of 
the human and mouse pART gene family members
The results of tBLASTn and BLASTn searches of the
human, mouse, and rat genome sequences yielded the
chromosomal localization and the exon/intron structure
of each pART gene family member. The chromosomal
localizations of the pART genes are represented schemati-
cally in Figure 2. All human and mouse pART orthologues
lie in regions of conserved synteny. There are three con-
served pART gene clusters containing two related para-
logues (pARTs 8 and 9; pARTs 12 and 13; pARTs 15 and
17). However, the two most closely related pairs of pARTs
(pARTs 5 and 6; pARTs 16 and 17) each are located on dif-
ferent chromosomes. All other pARTs are distributed as
single copy genes on different autosomes. In the human
genome, the cluster containing pARTs 8 and 9 also con-
tains pART7. Additional file 2 illustrates the local chromo-
somal environment of this pART gene cluster on human
chromosome 3q and the syntenic region on mouse chro-
mosome 16B3. The local order of genes is similar in the
human and mouse. However, the region corresponding to
pART7 is missing in the mouse. The corresponding region
is also missing in the rat genome (not shown).
The total number of exons in each pART gene is depicted
in Figure 2 and the exon structure of the catalytic domain
is illustrated schematically for the human pARTs in Figure
3. All intron positions within the coding region are fully
conserved in human and mouse orthologues. With the
sole exception of pART4 (VPARP), the catalytic domain is
encoded by the 3' terminal exons. Remarkably, in all
pART genes, with the exception of pART4 (VPARP) and
pART14 (TiPARP), the exons encoding the catalytic
domain are separated from the rest of the respectiveBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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Chromosomal localizations and exon compositions of the human and mouse pART family members Figure 2
Chromosomal localizations and exon compositions of the human and mouse pART family members. A) pART 
family members are sorted by subgroup on the basis of similarities in amino acid sequence, intron positions and associated pro-
tein domains. Color-coding of subgroups is as follows: 1 = red, 2 = pink, 3 = orange, 4 = green, 5 = grey. This color-coding is 
used in subsequent figures. Official gene designations, common aliases and accession numbers are shown. Exon compositions 
and lengths of open reading frames are given for the longest known or predicted gene transcripts. Available full length cDNAs 
from the Mammalian Gene Collection (MGC) are indicated with their respective accession numbers. MGC cDNAs which 
apparently do not contain the full open reading frame are indicated in parentheses. Hs = Homo sapiens, Mm = Mus musculus. B) 
Chromosomal localizations of pART genes were determined by tBLASTn searches of the respective genome sequences using 
the amino acid sequences of the catalytic domains of individual pARTs. Members of the five pART family subgroups are color-
coded as in A).
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Schematic diagram of the exon/intron structures of the regions encoding the catalytic domain of pART family members Figure 3
Schematic diagram of the exon/intron structures of the regions encoding the catalytic domain of pART family 
members. A) Exon/intron structures were determined by BLASTn searches of the human genome sequence with individual 
pART cDNA sequences. Only the exons corresponding to the catalytic domain of PARP-1 are shown. The coding region is 
marked in red, the 3' untranslated region (utr) is marked in white, and a blue bar marks the region corresponding to the cata-
lytic domain. Exons are represented as boxes with the width of each box reflecting the size of the respective exon (the 3' utr 
is not drawn to scale). Exon numbers are given with exon 1 corresponding to the exon encoding the presumptive initiation 
methionine. In all cases except pART4 (VPARP) the catalytic domain is encoded by the 3' terminal exons. Exon sizes (or size of 
coding region in case of the 3' exons) in basepairs are indicated on top of the boxes. Introns are depicted as triangles and are 
not drawn to scale. Intron sizes in base pairs are indicated on top of the triangles. The position of each intron with respect to 
the reading frame is indicated in the triangles (0 = between codons, +1 = between codon positions 1 and 2, +2 = between 
codon positions 2 and 3). Conserved exon boundaries are marked by colored arrows. Codons corresponding to the H-Y-E 
motif in the NAD binding crevice of DT and PARP-1 (see Fig. 1) are marked by yellow circles. B) The catalytic domain as delin-
eated in this paper is indicated by the dashed rectangle. For each pART the cDNA coding region within the catalytic domain is 
marked by a straight line, regions extending beyond this domain in the 5' direction (and in the 3' driection in case of pART4) 
are marked by dashed lines. The positions of the codons corresponding to the H, Y, E residues in the NAD-binding crevice are 
indicated by vertical lines. Intron phases are indicated by circles (phase 0), boxes (phase 1), and triangles (phase 2). Numbers 
indicate the distance in codons between the conserved histidine in β 1 and the next upstream phase 0 intron. Color-coding of 
conserved introns corresponds to that shown in A). Nonconserved introns are indicated in blue (filled) icons.
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coding exons by a phase 0 intron shortly upstream of the
codon for the first residue of the conserved H-Y-E catalytic
site motif, the conserved histidine in β 1 (Fig. 3). For most
pARTs, the amino acid sequences encoded by exons
upstream of this phase 0 intron do not show any detecta-
ble similarities, except for members of a particular sub-
group. We used the position of this phase 0 intron in
pART1 to delineate the N-terminal border of the catalytic
domain (e.g., see the green labeled end of the PARP-1-
model in Figure 1 and the dashed rectangle in Figure 3B).
The exon/intron structures of the pART catalytic domains
reveal a number of intriguing features (Fig. 3). The region
encoding the catalytic domain is disrupted by a remarka-
ble variety of introns with the number of introns varying
from one in subgroup 3 and in pART14 to six in pARTs 16
and 17. The catalytic domain of pART1 (PARP-1) and
those of its closest relatives in subgroup 1 are disrupted by
three (pARTs 3 and 4) or four (pARTs 1 and 2) introns.
Strikingly, not one of these 14 intron positions is con-
served. The catalytic domains of the two closely related
tankyrases in subgroup 2 each are interrupted by three
conserved introns. In subgroup 3, the catalytic domains of
pARTs 7–10 each contain a single conserved intron. The
pARTs of subgroup 4 (pARTs 11–14) share a single con-
served intron in their catalytic domains, pARTs 11–13
share a second conserved intron in the catalytic domain,
which is missing in pART14. The pARTs of subgroup 5
(pARTs 15–17) share two conserved introns in their cata-
lytic domains, pARTs 16 and 17 share four additional con-
served introns in the catalytic domain, which are missing
in pART15.
Conserved structural features revealed by multiple amino 
acid sequence alignments and secondary structure 
predictions
PSI-BLAST is a powerful, position sensitive iterative pro-
gram designed to detect distantly related proteins in the
protein database [35]. Initial matches in the first iteration
correspond to those detected by classic BLASTp searches
and typically reveal proteins with an amino acid sequence
identity to the query sequence of > 30%. PSI-BLAST then
derives a position specific scoring matrix from the aligned
protein sequences obtained in the first iteration, which is
then used for the subsequent search of the protein data-
base. This process is repeated in an iterative fashion until
no further matches are detected and the search 'con-
verges'. We performed PSI-BLAST searches of the protein
database using as query the amino acid sequences of the
catalytic domain of each member of the pART gene fam-
ily. Figure 4 schematically illustrates the tiling paths of
PSI-BLAST searches obtained with the stringent default
threshold setting (0.005 for the expect value) for a repre-
sentative member of pART family subgroups 1, 3, 4 and 5.
Typically, the other members of the same subgroup were
detected in the first iteration and obtained the highest
scores. The pARTs of other subgroups were usually
detected within two additional iterations, except in case of
pART15. Here, five iterations were required to detect all
pART family members.
The amino acid sequence alignments generated by PSI-
BLAST typically contained the highest degree of sequence
similarity in secondary structure motifs corresponding to
the NAD-binding cores in the known 3D structures of
chicken PARP-1 (1a26) and mouse PARP-2 (1gs0).
Separate multiple amino acid sequence alignments were
generated with T-Coffee for each of the pART subgroups
using the orthologous sequences from human and mouse
[36]. PSIPRED was used to predict secondary structure
units and GenTHREADER was used to predict the optimal
alignment of pART amino acid sequences with the 3D
structures of chicken PARP-1 and mouse PARP-2 [37]. In
all cases, predictions and alignments yielded consistent
results with respect to the sole alpha helix and five of the
six β-strands of the PARP-1 catalytic domain (see addi-
tional files 3, 4, 5, 6, 7: "Multiple amino acid sequence
alignments, secondary structure predictions and thread-
ing results for pART subgroups 1–5"). The small β strand
(β 4) at the upper edge of the active site crevice was
aligned and predicted congruently only for subgroups 1–
4, and could not be predicted with confidence for the
most distant relatives of PARP-1 (pARTs 15–17). Regions
corresponding to connecting loops showed significant
sequence identities only for members of a particular pART
subgroup. Most likely, these regions fold similarly only in
closely related pART family members.
A striking result of the alignment analyses is that the H-Y-
E catalytic site motif is fully conserved only in subgroups
1 and 2 (pARTs 1–6). All other pARTs show deviations
from this motif. The histidine in β 1 is conserved in 9 of
the 11 members of subgroup 3–5, the tyrosine in β 3 is
conserved in all family members, yet the presumptive cat-
alytic glutamic acid at the N-terminal end of β 6 is
exchanged in each of the pARTs 7–17.
Moreover, the amino acid sequence of the loop immedi-
ately upstream of β 5 and the active site glutamic acid res-
idue deviates markedly from those of PARP-1 and PARP-2
in most other family members except for the tankyrases
(pARTs 5 and 6). A growing body of evidence indicates
that this region influences the target specificity of pARTs
and mARTs [38-40]. In the 3D structure of PARP-1 with
carba-NAD (3pax), the ligand was found to interact with
this loop outside of the active site crevice, and it was pro-
posed that this may reflect the binding of the ADP-ribose
polymer in the target protein [14].BMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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Representative tiling paths of PSI-BLAST searches initiated with the catalytic domain amino acid sequences of selected pART  family members Figure 4
Representative tiling paths of PSI-BLAST searches initiated with the catalytic domain amino acid sequences of 
selected pART family members. PSI-BLAST searches were initiated with the catalytic domain amino acid sequences of the 
pARTs indicated on top as query sequences with the default threshold setting for the expect value of 0.005. Matching 
sequences from selected model organisms are indicated at the iteration in which they first appeared above threshold. pART 
subgroups are color coded as in Figure 2. Accession numbers of the indicated pARTs are listed in Figures 2 and 9. Species of 
origin is color-coded in the two letter abbreviation of the organism as follows: Homo sapiens (Hs) red, Drosophila melanogaster 
(Dm) and Anopheles gambiae (Ag) purple, Caenorrhabditis elegans (Ce) blue, Chilo iridescent virus (Ci) and Bacteriophage Aeh 
(Ba) brown.
input Hs.pART1 Hs.pART9 Hs.pART12 Hs.pART15 Ci.pART
iteration 1 Ag.pARTa Hs.pART8 Hs.pART11 Ag.pARTc Ag.pARTa
      = Dm.pARTa Hs.pART10 Hs.pART14 Hs.pART17 Hs.pART1
traditional Hs.pART2 Hs.pART7 Hs.pART13 Hs.pART2
Blastp Ce.pARTa Hs.pART13 Hs.pART7 Dm.pARTa
searches Hs.pART3 Hs.pART14 Hs.pART8
Ce.pARTb Hs.pART12 Hs.pART10
Hs.pART4 Hs.pART11 Ag.pARTb
Ce.pARTc Hs.pART6 Hs.pART16
Hs.pART5 Hs.pART5 Hs.pART6
Ci.pART Dm.pARTb
Ag.pARTb Hs.pART9
Dm.pARTb Hs.pART5
iteration 2 Hs.pART6 Ag.pARTb Hs.pART3 Hs.pART16 Hs.pART3
Hs.pART14 Dm.pARTb Dm.pARTa Hs.pART2 Ce.pARTa
Hs.pART13 Hs.pART3 Ce.pARTc Ag.pARTa Hs.pART4
Ba.pART Hs.pART1 Hs.pART1 Ce.pARTa Ce.pARTb
Hs.pART16 Dm.pARTa Hs.pART4 Ce.pARTc
Hs.pART7 Ce.pARTb Ce.pARTb Dm.pARTb
Hs.pART11 Hs.pART4 Ag.pARTa Hs.pART5
Ag.pARTc Ce.pARTc Hs.pART2 Ag.pARTb
Hs.pART17 Ag.pARTa Ce.pARTa Hs.pART6
Hs.pART12 Ci.pART Hs.pART14
Hs.pART16
Hs.pART7
Ba.pART
iteration 3 Hs.pART8 Hs.pART2 Hs.pART17 Dm.pARTa Hs.pART8
Hs.pART10 Ce.pARTa Hs.pART15 Hs.pART1 Hs.pART10
Hs.pART15 Hs.pART15 Ag.pARTc Hs.pART3 Hs.pART12
Hs.pART9 Ci.pART Ce.pARTc Hs.pART11
Ag.pARTc Ce.pARTb Hs.pART13
Hs.pART16 Hs.pART4 Ag.pARTc
Hs.pART17 Hs.pART5 Hs.pART17
Ba.pART Ag.pARTb Hs.pART15
Dm.pARTb
iteration 4 Hs.pART6 Hs.pART9
Hs.pART14
Hs.pART7
Hs.pART13
Hs.pART11
Ci.pART
Hs.pART12
Ba.pART
iteration 5 Hs.pART8
Hs.pART10
Hs.pART9
iteration 6 converged Ba.pART converged
iteration 7 converged converged
iteration 8 convergedBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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The results of the secondary structure prediction and
threading analyses were used to refine a multiple amino
acid sequence alignment of the catalytic domains of all
human pART family members. The resulting alignment is
shown in Figure 5. The conserved secondary structure
units corresponding to the catalytic NAD binding core
(the six beta strands and one alpha helix marked in Figure
1) are indicated schematically below the alignment. The
corresponding amino acid residues are highlighted in the
alignment. Intron positions are projected onto the amino
acid sequence in Figure 5. The positions of conserved
introns are marked by colored arrows below the align-
ment. Note that the alignment diverges most strongly
both in length and in sequence in the loops immediately
downstream and upstream of β 3.
Figure 6A shows a condensed version of the alignment in
which the diverging intervening loops are indicated only
by the number of amino acid residues. These 66 amino
acid residues can be superimposed well in the 3D struc-
tures of PARP-1, PARP-2, DT, and ETA. The respective
amino acid sequences of DT, ETA and the putative Chilo
iridescent virus pART are also shown for these regions. Fig-
ure 6B shows the calculated amino acid sequence identi-
ties of the pART family members in this region. The
percentage amino acid sequence identity in the aligned
core region is higher among members of a particular sub-
group than between members of different subgroups,
lending support to the subgroup assignments. For each
pART, the next most closely related paralogue is a member
of the same subgroup. Note that two pairs of pART para-
logues show very close sequence similarity: pARTs 5 and 6
(94% identity in the aligned core region) and pARTs 16
and 17 (86% identity). This close similarity is reflected
also in the conserved exon intron structures of the respec-
tive pART pairs (see Fig. 3).
Comparison of mouse and human pART orthologues
shows that seven of such pairs exhibit 100% sequence
identity in the aligned core region (pARTs 1, 5, 6, 11, 14,
16, and 17) and six show > 90% identity (pARTs 2, 3, 4,
10, 12, and 15). The mouse and human orthologues of
pARTs 8, 9, 13 show the least degrees of sequence identity
in this region (82%, 82%, and 70%, respectively) (Fig.
6B).
Phylogenetic analysis of the amino acid sequences of the
catalytic cores of pARTs resulted in three very similar trees
when using Maximum Parsimony (PAUP), Maximum
Likelihood (PhyML), and Bayesian Markov Chain Monte
Carlo (MrBayes) optimization criteria (Figure 7). All
topologies showed moderate to high support values for
the recovered relationships. All trees recovered five basic
clades corresponding to the subgroups 1–5. The results
indicate that pARTs of subgroups 1 and 2 are more closely
related (sistergroups) to one another than to members of
the other subgroups. A similar relationship is seen for
pARTs of subgroups 3 and 4. Note that the putative Chilo
iridescent virus pART clusters with the mammalian pARTs
of subgroup 1, suggesting that this large double stranded
DNA virus may have acquired its pART by horizontal gene
transfer.
The pART catalytic domain has become genetically fused 
to a wide spectrum of protein domains
With the exception of closely related members within a
subgroup, the amino acid sequence similarity between
pART family members breaks off upstream of β 1. Interest-
ingly, loss of sequence similarity correlates well with the
presence of a phase 0 intron upstream of β 1. All pART
family members except pART4 and pART14 contain such
a phase 0 intron 26–64 codons upstream of the conserved
histidine in β 1 (Fig. 3B).
Using the sequences flanking the catalytic domain of each
pART family member as queries, we performed further
PSI-BLAST analyses and searches of the Conserved
Domain Database [41]. The results, summarized in Figure
8, reveal that each of the 17 human pARTs with the possi-
ble exception of pART15 is a multi-domain protein. Strik-
ingly, the pART catalytic domain is associated – in a Lego
like fashion – with a broad spectrum of known protein
domains. In all family members except pART4 the cata-
lytic domain represents the C-terminal domain.
A number of associated domains occur in two or more
human pART family members. Note that domain sharing
generally is restricted to members of a particular pART
subgroup. For example, all members of subgroup 1 con-
tain a helical domain preceding the catalytic domain,
whereas this domain is missing in members of other pART
subgroups. The two members of subgroup 2 share SAM
and ankyrin-repeat domains. Three of four pARTs in sub-
group 3 share A1pp domains [42], all members of sub-
group 4 share WWE domains, and two members of
subgroup 5 contain a second, truncated pART domain,
reminiscent of the duplicated inactive ART domain found
in the VIP2 and iota mART toxins [16,23].
Several pARTs carry recognizable zinc-fingers containing
putative RNA-, DNA-, or ubiquitin-binding domains
(pART1, pART2, pART10, pART12, pART13). This indi-
cates that the genetic fusion of a pART catalytic domain
with zinc-fingers has occurred repeatedly in evolution.
Representation of pARTs in other model organisms
We also used PSI-BLAST to screen the protein database for
recognizable pART family members in other organisms
using as queries the amino acid sequences of catalytic
domains of each of the 17 human pARTs (Figure 9). TheBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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Multiple amino acid sequence alignment of the catalytic cores of the human pART family Figure 5
Multiple amino acid sequence alignment of the catalytic cores of the human pART family. The multiple sequence 
alignment was generated with T-Coffee and manually adjusted using the results of the PSI-BLAST, PSIPRED, and Gen-
THREADER analyses. Numbers at the sequence ends indicate the number of additional residues upstream and downstream of 
the alignment shown. Residues corresponding to the H Y E motif in the NAD binding crevice of diphtheria toxin are in red and 
marked by asterisks. The conserved β sheets and alpha helix are shaded in green and yellow. Conserved intron positions are 
marked in the multiple alignment using the same color-coding as in Figure 3. Conserved intron positions are indicated also 
above the alignment with arrows. Non-conserved intron positions are marked in blue in the alignment.
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Structure based amino acid sequence alignment of the catalytic cores of the pART gene family Figure 6
Structure based amino acid sequence alignment of the catalytic cores of the pART gene family. A) The alignment 
is restricted to those regions corresponding to the conserved secondary structure units of PARP-1 and DT as highlighted in 
Figure 1. The H Y E motif is marked by asterisks and is highlighted in red. Black numbers indicate amino acid residues from the 
N- and C-terminal ends of the protein and within the loops connecting the structure units shown. For proteins with known 3D 
structures the pdb accession number is given and the residues corresponding to respective secondary structure units are 
underlined. 1tox = diphtheria toxin; 1aer = pseudomonas exotoxin A, 3pax = chicken PARP-1 (pART1), 1gs0 = mouse PARP-2 
(pART2). Human and mouse pARTs are indicated by colored numbers. The sequence of the putative pART from Chilo irides-
cent virus is also shown for comparison (ci). B) Pairwise percentage sequence identities were calculated for the 66 amino acid 
residues shown in A), which correspond to the conserved core secondary structure units in Figure 1.
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** *
13 MENFSSYHGTKP 24 WKGFYSTDNKYDAAGYS 10 AGGVVKVTYPGL 45 VVLSL 7S V EYINNWEQKAALSVELEINF 368
457 GYVFVGYHGTFL 23 WRGFYIAGDPALAYGYA 12 NGALLRVYVPRS 32 LDAIT 7R L ETILGWPLAERTVVIPSIPT 40
851 HNRQLLWHGSRT 25 GKGIYFADMVSKSANYC 7 IGLILLGEVALG 18 HSVKG 35 YNEYIVYDV--AQVNLKYLLKL 9
49 KKTRLLIHGTRC 26 GEGNYFSEHVQKSLNYT 4 DQILLIYEVHVG 8 YNGDR 26 NSEIISYNE--DQSKIKYIIHI 2
854 HNRRLLWHGSRT 25 GKGIYFADMVSKSANYC 7 IGLILLGEVALG 18 HSVKG 35 YNEYIVYDI--AQVNLKYLLKL 9
854 HNRRLLWHGSRT 25 GKGIYFADMVSKSANYC 7 IGLILLGEVALG 18 HSVKG 35 YNEYIVYDI--AQVNLKYLLKL 9
420 HNRMLLWHGSRM 25 GKGIYFADMSSKSANYC 7 TGLLLLSEVALG 19 HSTKG 38 YNEYIVYNP--NQVRMRYLLKV 8
396 PNRMLLWHGSRL 25 GKGIYFADMSSKSANYC 7 TGLLLLSEVALG 19 HSTKG 38 YNEFIVYSP--NQVRMRYLLKI 8
383 GNRKLLWHGTNM 21 GKGIYFASENSKSAGYV 9 VGYMFLGEVALG 19 DSVIA 40 QSEYLIYQE--SQCRLRYLLEV 2
371 GNRRLLWHGTNV 21 GKGIYFASENSKSAGYV 9 VGYMFLGEVALG 19 DSVIA 40 QSEYLIYKE--SQCRLRYLLEI 2
430 GNVRPLLHGSPV 30 GSGIYFSDSLSTSIKYS 7 TRLLLICDVALG 19 DSVHG 12 DDEFVVYKT--NQVKMKYIIKF 1160
542 GNVRLLFHGSPV 30 GSGIYFSDSLSTSIKYA 7 SRLLVVCDVALG 19 DSVHG 12 DDEFVVYKT--NQVKMKYIVKF >672
1176 HNERMLFHGSPF 20 GAGIYFAENSSKSNQYV 20 HRQMLFCRVTLG 18 HSVIG 8 YAEYVIYRG--EQAYPEYLITY 19
1169 HNERMLFHGSPF 20 GAGIYFAENSSKSNQYV 20 HRQMLFCRVTLG 18 HSVIG 8 YAEYVIYRG--EQAYPEYLITY 19
1023 ANERMLFHGSPF 20 GAGIYFAENSSKSNQYV 20 HRQLLFCRVTLG 18 HSVTG 8 LAEYVIYRG--EQAYPEYLITY 11
1194 ANERMLFHGSPF 20 GAGIYFAENSSKSNQYV 20 HRQLLFCRVTLG 18 HSVTG 8 LAEYVIYRG--EQAYPEYLITY 11
317 NNERLLFHGTDA 23 GKGTYFAVDASYSAKDT 8 RKHMYVVRVLTG 24 DSVTN 4 PKLFVVFFD--NQAYPEYLITF 2
1391 MNEKQLFHGTDA 23 GKGTYFAVNANYSANDT 8 RKHVYYVRVLTG 24 DTVTD 4 PSLFVAFYD--YQAYPEYLITF 2
1408 RNEKHLFHGTEA 23 GKGTYFAVKASYSACDT 8 RKYMYYVRVLTG 24 DTVTD 4 PSIFVVFYD--NQTYPEYLITF 2
697 PVSHRLFQQVPY 23 GAGIYFTKNLKNLAEKA 8 LIYVFEAEVLTG 23 DSVVD 4 PETFVIFSG--MQAIPQYLWTC 33
668 SGSQRLFQQVPH 23 GAGIYFTKSLKNLADKV 8 LIYVFEAEVLTG 23 DSVVD 4 PETIVVFNG--MQAMPLYLWTC 38
879 PVEQVLYHGTTA 23 GKGVYFAKRASLSVQDR 8 HKAVFVARVLTG 24 DSAVD 4 PSIFVIFHD--TQALPTHLITC 21
828 PVEQVLYHGTSE 23 GQGVYFAKRASLSVLDR 8 YKAVFVAQVLTG 23 DSAVD 4 PRIFVIFHD--TQALPTHLITC 8
189 INEQMLFHGTSS 23 GKGTYFARDAAYSSRFC 25 YKSMFLARVLIG 23 DSCVD 4 PKIFVVFDA--NQIYPEYLIDF 1
189 INEQMLFHGTSS 23 GKGTYFARDAAYSSRFC 25 YKSMFLARVLIG 23 DSCVD 4 PKIFVVFDA--NQIYPEYLIDF 1
556 VDERQLFHGTSA 23 GKGSYFARDAAYSHHYS 5 THTMFLARVLVG 23 DSCVN 4 PSIFVIFEK--HQVYPEYVIQY 24
566 VDERQLFHGTSA 23 GKGSYFARDAAYSHHYS 5 SHMMFLARVLVG 23 DSCVN 4 PTIFVVFEK--HQVYPEYLIQY 24
779 EEGKLLFYATSR 23 GKGIYFAKDAIYSHKNC 5 NVVMFVAQVLVG 16 DSCVD 4 PSVFVIFQK--DQVYPQYVIEY 9
870 KTEMFLFHAVGR 23 GKGNYFTKEAMYSHKSC 5 GTVMFVARVLVG 16 DSCVD 4 PSVFVIFRK--EQIYPEYVIEY 12
524 INERHLFHGTSQ 23 GQGSYFAKKASYSHNFS 6 VHFMFLAKVLTG 25 DSCVD 4 PQIFVIFND--DQSYPYFVIQY 9
524 INERHLFHGTSQ 23 GQGSYFAKKASYSHNFS 6 VHFMFLAKVLTG 25 DSCVD 4 PQIFVIFND--DQSYPYFVIQY 9
144 RDLIYAFHGSRL 21 GEGTYLTSDLSLALIYS 23 IDHPDVKCQTKK 6 DRRRA 11 PKYFVVTNN--QLLRVKYLLVY 51
144 RDLIYAFHGSRL 21 GEGTYLTSDLSLALIYS 23 IDHPDVKCQIKK 6 DRSRA 11 PKYFVVTNN--QLLRVKYLLVY 51
689 FGSTFAFHGSHI 26 GSGIYLSPMSSISFGYS 35 LQSRNLKCIALC 6 DLHKH 0 GEIWVVPNT--DHVCTRFFFVY 32
687 FGSTFAFHGSHI 26 GSGIYLSPMSSISFGYS 35 LQSRNLKCIALC 6 DLHKH 0 GEIWVVPNT--DHVCTRFFFVY 32
465 YGSTFAFHGSHI 26 GKGIYLSPISSISFGYS 35 LQSRNLNCIALC 6 DLQKH 0 GNIWVCPVS--DHVCTRFFFVY 32
465 YGSTFAFHGSHI 26 GKGIYLSPISSISFGYS 35 LQSRNLNCIALC 6 DLQKH 0 GNIWVCPVS--DHVCTRFFFVY 32
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ci 15 18 *** 36 38 36 32 36 30 32 26 26 15 21 21 27 24 27 18 17 15 ci
g01 18 17 36 *** 97 79 56 47 47 44 33 29 23 26 33 27 26 26 23 26 26 g01
h01 18 17 38 97 *** 79 56 49 49 46 35 29 23 24 32 29 26 27 23 26 26 h01
m01 18 17 38 97 100 79 56 49 49 46 35 29 23 24 32 29 26 27 23 26 26 m01
h02 18 20 36 79 79 *** 58 50 47 46 33 27 21 24 32 29 26 27 23 30 29 h02
m02 17 21 36 76 76 92 53 52 44 44 35 29 26 27 33 30 27 27 24 29 29 m02
h03 20 20 32 56 56 58 *** 36 44 41 36 33 29 32 33 35 36 33 21 23 24 h03
m03 20 20 35 56 58 55 95 41 46 42 38 32 29 32 33 36 33 35 21 23 24 m03
h04 15 18 36 47 49 50 36 *** 46 47 38 29 26 26 32 33 27 30 24 30 26 h04
m04 14 17 32 46 47 47 36 91 44 46 39 29 29 26 32 30 29 29 26 30 26 m04
h05 15 17 30 47 49 47 44 46 *** 94 46 41 35 38 39 41 32 38 21 24 23 h05
m05 15 17 30 47 49 48 44 46 100 94 46 41 35 38 39 41 32 38 21 24 23 m05
h06 15 17 32 44 46 46 41 47 94 *** 46 42 35 38 38 39 30 36 21 24 23 h06
m06 15 17 32 44 46 46 41 47 94 100 46 42 35 38 38 39 30 36 21 23 23 m06
h07 17 15 26 33 35 33 36 38 46 46 *** 79 36 55 62 55 47 50 29 17 17 h07
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h10 14 20 21 26 24 24 32 26 38 38 55 55 46 *** 52 50 46 52 20 15 17 h10
m10 12 20 21 24 23 23 30 26 33 33 50 50 46 91 52 47 47 55 20 15 15 m10
h11 14 15 21 33 32 32 33 32 39 38 62 55 35 52 *** 64 53 59 24 20 20 h11
m11 14 15 21 33 32 32 33 32 39 38 62 55 35 52 100 64 53 59 24 20 20 m11
h12 15 17 27 27 29 29 35 33 41 39 55 50 33 50 64 *** 62 67 24 23 24 h12
m12 15 17 26 29 30 29 32 33 39 38 56 49 32 47 65 94 59 65 26 24 24 m12
h13 9 12 24 26 26 26 36 27 32 30 47 42 39 46 53 62 *** 56 18 17 18 h13
m13 11 7 24 21 21 23 30 26 38 36 47 44 39 47 55 61 70 53 20 15 17 m13
h14 11 12 27 26 27 27 33 30 38 36 50 47 36 52 59 67 56 *** 21 26 24 h14
m14 11 12 27 26 27 27 33 30 38 36 50 47 36 52 59 67 56 100 21 26 24 m14
h15 17 15 18 23 23 23 21 24 21 21 29 21 18 20 24 24 18 21 *** 30 26 h15
m15 17 15 18 23 23 23 21 24 20 20 29 21 18 20 24 24 18 21 97 30 26 m15
h16 11 9 17 26 26 30 23 30 24 24 17 14 15 15 20 23 17 26 30 *** 86 h16
m16 11 9 17 26 26 30 23 30 23 23 17 14 15 15 20 23 17 26 30 100 86 m16
h17 12 9 15 26 26 29 24 26 23 23 17 15 14 17 20 24 18 24 26 86 *** h17
m17 12 9 15 26 26 29 24 26 23 23 17 15 14 17 20 24 18 24 26 86 100 m17
ddt aer ci g01 h01 h02 h03 h04 h05 h06 h07 h08 h09 h10 h11 h12 h13 h14 h15 h16 h17
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Phylogram of the evolutionary relationship of the pART family Figure 7
Phylogram of the evolutionary relationship of the pART family. Evolutionary relationships of the amino acid 
sequences in the catalytic core of the pARTs shown in Figure 6 are illustrated as a maximum a posteriori phylogram (MAP) of 
Bayesian Markov Chain Monte Carlo analysis (pP = 0.92). Posterior probabilities were converted into percentages and are 
shown above the branches. Members of the five pART family subgroups are color-coded as in Figure 2: subgroup 1 = red, 2 = 
pink, 3 = orange, 4 = green, 5 = grey. Hs = Homo sapiens, Mm = Mus musculus.
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order in which PSI-BLAST picked up putative pART
sequences from the database in successive iterations was
similar for different members of a particular pART sub-
group but differed markedly for members of different sub-
groups (see additional file 8: "Representative tiling paths
of PSI-BLAST searches initiated with the catalytic domain
Schematic diagram of the domain structures of human pARTs and pARTs from distantly related organisms Figure 8
Schematic diagram of the domain structures of human pARTs and pARTs from distantly related organisms. 
Recognizable protein domains in the pART family are represented by the icons defined on the right. The domain structures of 
human pARTs (on the left, numbered Pacman icons) and related pARTs from other species are illustrated schematically. Poten-
tial DNA binding domains are boxed in red, potential ubiquitylation motifs are boxed in green. Members of the five pART fam-
ily subgroups are grouped within colored boxes using the color-coding as in Figure 2: subgroup 1 = red, 2 = pink, 3 = orange, 
4 = green, 5 = grey. Amino acids corresponding to the HYE catalytic site motif of DT and PARP-1 are shown in the mouths of 
the Pacman icons. Black numbers indicate protein lengths in number of amino acids. Species of origin is color-coded in the two 
letter abbreviation of the organisms as in Figures 4 and 9: Drosophila melanogaster (Dm) and Anopheles gambiae (Ag) purple, 
Caenorrhabditis elegans (Ce), Dictyostelium discoideum (Dd), Entamaoeba histolytica (Eh), and Gibberella zeae (Gz) blue, Arabidopsis 
thaliana (At) green, Chilo iridescent virus (Ci) and Bacteriophage Aeh (Ba) brown. Protein database accession numbers for the 
illustrated pARTs are listed in Figures 4 and 9. On the right, the approximate size of each domain is indicated in number of 
amino acid residues. The accession numbers of the respective domain families in the pfam, cd, and smart databases are indi-
cated. In case of zinc finger (zf) containing domains, the number of recognizable zinc fingers is indicated by colored bars within 
the icon.
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amino acid sequences of selected pART family mem-
bers"). In many instances, PSI-BLAST detected pART
sequences from distantly related organisms in earlier iter-
ations than the human pART paralogues from other
subgroups.
Figure 9 summarizes the matches of pART-related proteins
found in model organisms with completed genome
sequences. On the basis of amino acid sequence similar-
ity, conserved intron positions and/or conserved associ-
ated domains, pARTs from other vertebrates including
fish and chicken, generally can be assigned to a particular
human pART orthologue. In contrast, pARTs of lower
eucaryotes can be assigned to a subgroup but not to a par-
ticular vertebrate pART.
pART homologues were found in many model organisms
from the animal, plant, fungi, and protist kingdoms. The
recently completed genome of the pufferfish T. nigroviridis
contains recognizable orthologues for all pARTs except for
pARTs in distantly related species Figure 9
pARTs in distantly related species. pART relatives were identified by PSI-BLAST searches as in Figure 4. Matching 
sequences from other organisms were sorted by group on the basis of sequence similarity and associated domains. Accession 
numbers are given for pARTs from Homo sapiens (human), Mus musculus (mouse), Gallus gallus (chicken), Tetraodon nigroviridis 
(puffer fish), Drosophila melanogaster (fruit fly), Anopheles gambiae (malaria mosquito), Caenorhabditis elegans (nematode), Dictyos-
telium discoideum (slime mold), Gibberella zeae (ear root microfungus), Entamaoeba histolytica (amoeba), Arabidopsis thaliana 
(cress plant), Chilo iridescent virus and Bacteriophage Aeh1 (viruses), Pseudomonas aeruginosa, Corynebacterium diphtheriae and 
Vibrio cholerae (bacteria). Lower case letters in black indicate the pART designations used in Figure 8.
pART protein aliases human mouse chicken fish fly mosquito
1 PARP1 PARP P09874 NP_031441 NP_990594 CAG09179 P35875 a XP 312938 a
2 PARP2 Q9UGN5 NP_033762 CAF92030
3 PARP3 AAM95460 NP_663594 CAG06805
4 PARP4 vaultPARP AAD47250 XP_283217 XP_417150 CAG08214
5 TNKS Tankyrase AAC79841 AAH57370 NP_989671
6 TNKS2 Tankyrase 2 NP_079511 XP_129246 NP_989672
7 PARP15 NP_689828 ---
8 PARP14 AAN08627 XP_488522 XP_422113
9 PARP9 BAL NP_113646 NP_084529 XP_422116
10 PARP10 BAB55067 AAH24074 CAG05989
11 PARP11 AAF91391 NP_852067 XP_416489 CAG01913
12 ZC3HDC1 NP_073587 NP_766481 XP_416333
13 ZC3HAV1 ZAP NP_064504 BAB32047 XP_423977
14 TIPARP TiPARP NP_056323 NP_849223 XP_422828 CAF96664
15 PARP16 AAH31074 NP_803411 XP_413903 CAG05566 XP 308419 c
16 PARP8 NP_078891 AAH21881
17 PARP6 CAB59261 XP_134863
pART protein nematode slime mold fungi amoeba weed viruses bacteria
1 PARP1 AAM27195 a
2 PARP2
3 PARP3 Q09525 b
4 PARP4
5 TNKS
6 TNKS2
7 PARP15
8 PARP14
9 PARP9
10 PARP10
11 PARP11
12 ZC3HDC1
13 ZC3HAV1
14 TIPARP
15 PARP16
16 PARP8
17 PARP6
EAL43406_c
EAL50270_d
EAL49071_e
EAL45174 f
AAF56487_b
CAF98988
CAG12587
CAG05573
CAF95416
CAG12585
CAG04910
XP_321116_b
CAD59237_a
CAD58666_c
CAD59238_d
CAD59240_e
NP_850165_a
CAA88288_b
BAB09119_c
EAA75569_a
AAB94432
AAQ17796
1AERA
760286A
AAW80252
XP_424786
CAF98285
CAF96305
EAA73885_c
EAL47198_a
EAL50270_b
AAC04454_c CAD59239_b
AA051129 f
AAS38928_g
NP_849739_d
AAC36170_eBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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pART7 [43]. The nearly completed albeit still fragmentary
chicken genome contains recognizable orthologues for all
pARTs except for pARTs 2, 3, 7, 10, and 17 [44]. Simpler
eucaryotes generally contain fewer pARTs (two in the fruit
fly D. melanogaster, three each in the malaria mosquito A.
gambiae, the nematode C. elegans, and the ascomycete G.
zeae; six in the amoeba E. histolytica, nine in the slime
mold D. discoideum, and ten in the cress plant A. thaliana).
Remarkably, the yeast S. cerevisae and the archaea lack
detectable pARTs. Only two matches were found in the
viral proteome: these derive from two double stranded
DNA viruses: the insect virus Chilo iridescent virus and
the bacteriophage Aeh1. Although PSI-BLAST initially
failed to connect the pART family with Diphtheria toxin
and Pseudomonoas exotoxin A, these toxins were readily
connected with the eucaryotic pARTs when using as query
a chimera, e.g. of Diphtheria toxin and Chilo iridescent
virus pART in which the sequences of three of the con-
served structure units highlighted in Figures 1 and 6A were
interchanged. These searches uncovered a DT/ETA-like
putative ADP-ribosyltransferase in V. cholerae, but no
other proteins in the microbial proteome in GenBank.
Of note, none of the known R-S-E motif bacterial or verte-
brate mARTs were ever connected by PSI-BLAST with the
DT/ETA/pART group. In several cases, however, we
observed intriguing matches just slightly below threshold
(in the region surrounding the conserved H in β 1) to
members of the family of RNA:NAD 2' phosphotrans-
ferases. These enzymes catalyze a reaction during tRNA
splicing that is similar to the reaction catalyzed by ARTs,
but in which ADP-ribose is transferred to the 2'-phosphate
in immature tRNA rather than to an amino acid residue in
a protein [25]. The 3D-structure of a prototype member of
this gene family, indeed, reveals a structure closely resem-
bling that of PARP-1 and Diptheria toxin (see Fig. 1), pro-
viding strong support for the relevance of the matches
detected by PSI-BLAST.
For the pART homologues shown in Figure 9 we also ana-
lyzed the sequences flanking the pART catalytic domain
for associated conserved domains. The results reveal that
many pARTs, even from very distantly related organisms,
share domain associations found in human and mouse
pARTs. Some of these are illustrated in Figure 8. For exam-
ple, the association of regulatory, BRCT, and DNA
binding domains observed in pART1 (PARP-1) is found
also in similar proteins encoded by fruit fly, nematode,
microfungi and cress plant genomes. Tankyrase-like asso-
ciation with ankyrin repeats is found in pARTs from the
fruit fly and nematode. The association of a pART catalytic
domain with an A1pp domain, as seen in human pART
subgroup 3, is found also in a pART from the slime mold
Dictyostelium discoideum. The combination with a WWE
domain, as seen in human pART subgroup 4, is found also
in putative pARTs from cress plant. A domain
corresponding to the unknown upstream region of the
smallest human pART (pART15) is observed also in a
pART from the malaria mosquito Anopheles gambiae, and
a duplicated truncated pART catalytic domain as in pARTs
16 and 17 is observed also in a pART from the microfun-
gus Gibberella zeae. These results indicate that many of the
domain combinations observed in human and mouse
pARTs represent evolutionary ancient inventions.
Some pARTs of distantly related proteins are associated
with domains not found in any of the human pARTs. A
striking example is that of G. zeae pARTc, which most
closely resembles human pARTs 16 and 17, but is associ-
ated with a second potential catalytic, ubiquitin ligase
domain (Fig. 8). A similar pART is found also in the
related microfungus Aspergillus nidulans [GenBank:
EAA66581]. These microfungal pARTs are the only
examples found so far, in addition to vertebrate pART4,
where a distinct domain(s) is genetically fused to the C-
terminal end of the pART catalytic domain. The large
domain(s) associated with the putative pART from bacte-
riophage Aeh1 does not bear any resemblance to pART-
associated domains in vertebrates but shows distant simi-
larity to viral coat proteins. The only organism containing
an isolated pART domain reminiscent of the isolated ART
domain found in verbetrate mARTs [27] is the Chilo iri-
descent insect virus. This "naked" viral pART catalytic
domain contains the H-Y-E motif of PARP-1 and DT. It
will be interesting to determine whether this protein
exhibits the predicted pART activity.
A striking example of domain shuffling is observed in one
of the three C. elegans pARTs: like the human tankyrases
(pARTs 5 and 6), Ce.pARTc contains ankyrin repeats, but
also harbors the regulatory and WGR domains typical of
human group 1 pARTs instead of the SAM domain found
in human pARTs 5 and 6 (Fig. 8). A similar variation of
domains as in Ce.pARTc is found also in one of the ten
pARTs of D. discoideum (Dd.pARTb).
Finally, we addressed the question whether the striking
differences in exon/intron compositions of the closest
PARP-1-homologues in groups 1 and 2 might be reflected
in similar differences in pART orthologues of distantly
related species. To this end we determined the exon/
intron structures of distant pART orthologues by BLASTn
searches of the respective genome databases using cDNA
sequences as queries; and compared the results with those
obtained for human pART genes. The results are illus-
trated schematically in Figure 10, with conserved intron
positions highlighted. As in case of most other genes, the
pART genes of 'lower' animals, protists, and plants in gen-
eral contain fewer and shorter introns than the humanBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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Schematic diagram of the exon/intron structures of pART family members of distantly related organisms Figure 10
Schematic diagram of the exon/intron structures of pART family members of distantly related organisms. A) 
Exon/intron structures were determined by BLASTn searches of the genome browsers using the pART cDNA sequences. The 
positions of codons corresponding to the H Y E motif in the NAD-binding crevice of diphtheria toxin are marked by yellow 
circles. The position of the conserved glycine and arginine pair of residues within the WGR domain is marked in blue. Coding 
regions for catalytic and other domains are indicated by colored bars. Conserved introns are marked by colored arrows. B) 
The diagram contains only those introns that are conserved in at least two distantly related species. Color-coding of the 
introns corresponds to that shown in A). The position of codons encoding/corresponding to the H, Y, E residues in the NAD 
binding crevice are indicated by vertical lines. The position of each intron with respect to the codon is indicated by circles 
(phase 0 introns), boxes (phase 1 introns), and triangles (phase 2 introns). Coding regions for catalytic and other selected 
domains are indicated by colored lines as in A).
Dm.pARTb
5 6 7
293 157 135
3 4
158 783 688
2394
2 1
64
1881
60 64 68 60
E Y H
11 2 10 0
Dm.pARTa
12 2 2 0
5 4 3 2
1344 570 534 334 142 190
1 6
6500 1300 55 36000 >20000
GR E Y H
2 3 4 5 6 7 8 9 10 12 13 14 16 17 19 20 23 1 15 18 21 22 11
281 166 116 215 100 117 177 148 141 243 69 133 196 129 84 123 129 99 153 128 62 115 737
GR
5430 9899 1574 1654 2213 645 2320 1827 903 280 298 1838 2753 3708 2112 590 1427 799 931 782 1015 427
Hs.pART1
E Y H
12 1 2 00 1 0 00 0 1 1 12 0 0 0 00 0 2
901 441 3680
23 24
75 106 187
25
H Y
26
157 232
6387
27
E
22
98
1471 1510
21
121
8889
20
83
697
238
19
3396
189
18
12537
17
110
292
220
16
1420
15
166
2243
14
146
4169
13
80
6095
12
172
10153
11
79
10
92
95 1462
9
122
8
187
1373 557 1429
7
67
6
95
35198 64273 737 28862 23546
5
76
4
37
3
96 225
2
678
1
Hs.pART5
12 0 2 11 12 0 0 00 02 1 1 0 1 1 12 00 0 0 0
543
1
E Y H
Ci.pART
5 6 9
236 130 56 47 50
3 4
82 146 268 212
2
77 81 92 181 196 214 76
10
107
11
63
93
12
81
13
111
109 91
14
76
103
143
15
121 111 86
16
74
17
106 198
18 1
GR
74
93 117
7 8 At.pARTb
E Y H
01 0 01 2 00 12 0 0 11 00 0
5 8 9
205 237 216 254 79
3 4 2
578 123 720 93
2145 46 65 649 1094 1653 5407 1551
6
333
7
1390
10 1
GR
Ce.pARTa
E Y H
00 2 00 20 00
326
3 4
125 698 78 556
2
44 91 49 47
5 1
GR
Ce.pARTb
E Y H
10 2 1
49
1 5 6 7 8 9
114 2295 245 343 432 645
10 3 4 11 2
1712 199 554 88 204
1335 50 77 119 46 488 49 51 59
GR
Ce.pARTc
E Y H
0 10 0 10 0 20 0
At.pARTa
97 111 149 99 72 82 84 83
16
83
103 93 83 110 129 229
18
183 273
19
92
E
138
17
Y
136
109
15
H
14
183
13
161
12
77 113
11 10
484
9
64
8
61
7
162
6
196
5
282
4
187
3
217
80
50
2
749
294
1
GR
0 1 20 0 1 20 0 1 20 0 1 20 0 0
14 15 16
E
128 100 99 125 260
155 361 246 117
13
Y H
12
275
135
11
181
64
10
804
139
9
561
163
8
1737
103
7
1122
76
6
424
97
5
3612
51
4
1398
71
3
267
195
1244
53 Hs.pART2
GR
12 02 11 12 00 00 02 0
2 1
CDR Intron conserved exon-intron-boundaries ca.200bp
pART cd pART rd WGR SAM Ankyrin BRCT
utr domains
Zn finger SAP
Hs.pART1
Hs.pART2
Hs.pART5
Dm.pARTa
Dm.pARTb
Ce.pARTa
Ce.pARTb
At.pARTa
At.pARTb
phase 1 intron phase 0 intron phase 2 intron
E Y H
pART cd pART rd WGR Ankyrin
B
ABMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
Page 17 of 23
(page number not for citation purposes)
homologues. However, some of the introns found in
human pART genes are found also in homologues of
distantly related organisms. For example, all six introns
observed in D. melanogaster pARTb are found in corre-
sponding positions also in human pART5 (tankyrase 1);
yet human pART5 contains 14 additional introns not
found in the fruit fly pART. The other pART of the fruit fly
shares two of its five introns with human pART1 (PARP-
1). The three pARTs of the nematode C. elegans show a dif-
ferent, only partially overlapping set of conserved introns:
Ce.pARTa shares seven of its nine introns with human
pART1, Ce.pARTb shares three of its four introns with
human pART2, whereas Ce.pARTc does not seem to share
any of its introns with pART5, despite the similar domain
organization on the protein level (see Fig. 8). The pARTs
from the model plant Arabidopsis thaliana contain a fairly
high number of introns, however only very few intron
positions correspond to ones found also in human pARTs.
For example, At.pARTa which is most closely related to
human PARP-1 in terms of amino acid sequence similar-
ity and organization of conserved protein domains, evi-
dently does not share any of its 18 introns with human
pART1. Strikingly, however, the introns found in the cata-
lytic domain of this pART exhibit conserved positions
with two different human pARTs: two of the four intron
positions in the catalytic domain of At.pARTa are found in
corresponding positions in human pART5 (tankyrase),
another intron is found at a corresponding position in
human pART2 (Fig. 10), whereas the fourth intron is not
found in any human pART. At.pARTb which is most
closely related to human pART2 in terms amino acid
sequence similarity and domain organization, shares one
of its 17 introns with human pART2. Note further, that in
only two cases (Chilo iridescent virus pART and pARTa of
the fruit fly), the pART catalytic domain lacks introns, i.e.
is encoded by a single exon as in case of the vertebrate
mARTs [27].
Discussion
The results of our study illustrate the great power and util-
ity of the public genome databases and database search
programs. Moreover, they provide important novel
insights into the molecular structure and evolution of the
pART gene family.
Our results differ in some details from those of a recent
report by Ame and coworkers [11]. These discrepancies
can be explained by errors in the draft sequence of the
human genome available at the time of the previous
report. For example, the database entry AK023746 given
by Ame et al. for PARP-5c evidently represents a truncated
cDNA for pART6 (alias tankyrase 2 or PARP-5b). This
entry contains two point mutations and a 65 bp deletion
in the 3' utr vs. the cDNA and genomic sequences of
pART6. Blast analyses of the high quality sequence of the
human genome and of the EST database with the
AK023746 sequence provide no evidence for a distinct
copy of this gene in the human genome. We conclude that
the PARP-5c gene identified by Ame et al. represents an
allelic variant or cloning/sequencing error rather than a
genuine pART gene family member; i.e. that the total
number of human pART genes is 17 rather than 18 sug-
gested in the previous report. Large discrepancies exist
also in the number of amino acids assigned in the two
reports for pART7/PARP-15 (444 vs. 989) and for
pART16/PARP-8 (854 vs. 501). The earlier database
entries for PARP-8 (XM_018395) and PARP-15
(XM_093336) have hence been removed as a result of
standard genome annotation processing because these
entries evidently contained frameshift mutations and/or
fused cDNA sequences that led to erroneous amino acid
assignments. Similarly, the small differences in assign-
ments for five other PARPs/pARTs can be accounted for by
differences in the draft vs. high quality sequence of the
human genome (Ame et al./our study): pART2/PARP2
(583/570), pART3/PARP3 (540/533), pART10/PARP10
(1020/1025), and pART14/PARP7 (657/680).
We assigned the 17 human pARTs into five distinct sub-
groups (Fig. 2). This assignment is supported by several
independent lines of evidence: Firstly, members of a par-
ticular subgroup show higher amino acid sequence
identities to one another than to members of other sub-
groups (Fig. 6). This is reflected in the tiling paths of PSI-
Blast searches, where members of the same subgroup were
detected in the first iteration, whereas members of other
subgroups generally were detected in later iterations (Fig.
4). Secondly, members of a particular subgroup typically
share one or more associated domains not found in mem-
bers of other subgroups (Fig. 8); pARTs 8, 10 and 15 pose
exceptions to this rule. Thirdly, members of a particular
subgroup typically share one or more intron positions not
found in members of other subgroups (Fig. 3); pARTs 1–
4 pose notable exceptions to this rule. Fourthly, when
genes of two or more pARTs are physically linked in a clus-
ter on the same chromosome, they belong to the same
subgroup – possibly reflecting regional duplications (Fig.
2). Finally, results of all phylogenetic analysis converged
in topologies with clearly distinct clades for each of the
subgroups (Fig. 7). Members of subgroups 1 and 2 evi-
dently are more closely related to one another than to
other subgroups (Figs. 6 and 7). Similarly, members of
subgroups 3 and 4 are sister-groups to one another, indi-
cating a close relationship.
Members of the pART family are found fused to a striking
variety of associated domains (Fig. 8). It is not farfetched
to hypothesize that the associated domains direct the
respective pARTs to subcellular structures and/or target
proteins. Genetic fusion of group 1 and group 2 pARTsBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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with DNA-binding domains is in line with their estab-
lished roles in DNA-repair, chromosome remodeling, and
mitotic spindle formation [9,11,12]. Moreover, the SAM
and ankyrin domains of pARTs 5 and 6 have been shown
to mediate interactions with target proteins in telomere-
associated protein complexes [45]. Similarly, the C-termi-
nal domain of pART4 evidently plays a role in targeting
pART4 to the major vault particles [46]. A flurry of
domains implicated in the ubiquitination pathway point
to a possible connection between ubiqutitination and
ADP-ribosylation. Indeed, it has recently been reported
that ADP-ribosylation of TRF1 by tankyrase (pART5)
results in the release of the protein from telomers and its
subsequent ubiquitination [47]. Strikingly, pARTs from
the microfungi G. zea and A. nidulans provide examples
for the genetic fusion of two enzyme domains catalyzing
these post-translational protein modifications into a sin-
gle polypeptide.
So far, only a single example of a 'naked' pART catalytic
domain akin to the isolated catalytic domain of the verte-
brate ecto-ARTs 1–5 [27] was recovered from the public
database. This putative pART from Chilo iridescent virus
clusters with the mammalian pARTs of subgroup 1 (Fig.
7), suggesting that this large double stranded DNA virus
[48] may have acquired its pART by horizontal gene
transfer.
The definition of the pART catalytic domain proposed in
this paper is somewhat smaller than that commonly used
in the field [11]. We used the position of the common
phase 0 intron upstream of the first conserved β sheet to
set the N-terminal end of the catalytic domain (e.g. see
Figs. 1 and 3B). The pARTs of subgroup 1 are extended N-
terminally of this position by an alpha helical domain
(Fig. 8) which is often included as part of the PARP-1 cat-
alytic domain. However, since other pART family mem-
bers lack this region, we propose to omit it from the
proper pART catalytic domain. Moreover, this N-terminal
delineation of the catalytic domain corresponds well to
the N-terminus of the 'naked' pART of Chilo iridescent
virus as well as to those of Diphtheria toxin and Pseu-
domonas exotoxin A after proteolytic processing of the
signal sequence or translocation domain (Fig. 1).
With the exception of pART4, the group 1 pARTs are
extended upstream of this helical region by another
domain named after its conserved motif of tryptophane
(W) – glycine (G) – arginine (R) residues. This WGR
domain is found also in poly-A-polymerases, its function
is unknown. Many group 1 pARTs from distantly related
organisms, e.g. plants, insects, nematodes, and micro-
fungi, also contain these two domains. Interestingly, in
Drosophila melanogaster pARTa these three domains (WGR,
helical, catalytic) are encoded by a single, large exon (Fig.
10). Human pARTs 5–17 lack the WGR and helical
domains. However, pART5/6 (tankyrase)-like pARTs from
C. elegans (Ce.pARTc) and D. discoideum (Dd.pARTb) con-
tain the WGR and helical domains whereas a SAM
domain is found at this position in human pARTs 5 and 6
(Fig. 8).
A puzzling finding is the lack of conservation of the classic
H-Y-E motif found in the catalytic cores of PARP-1, PARP-
2, Diphtheria toxin and Pseudomonas Exotoxin A (Fig. 1).
This motif is conserved only in members of subgroups 1
and 2. All other human pARTs carry notable variations
from this motif. In particular, all other pARTs carry a
replacement of the glutamic acid residue in β 5, i.e. the
residue that was shown to be critical for the catalytic activ-
ities of DT, PARP-1 and many other pARTs and mARTs
[6,7,20,21]. In six cases, this glutamic acid is replaced by
an isoleucine residue, in two cases by leucine, and in one
case each by threonine, valine, or tyrosine. Enzyme
activity has been reported recently for two of the six pARTs
that carry an H-Y-I motif instead of the H-Y-E motif
(pARTs 10 and 14) [32,34]. Thus, it is not unlikely that the
four other pARTs carrying the H-Y-I motif turn out to be
active enzymes (pARTs 11, 12, 16, and 17). Mouse pART8
also carries an H-Y-I motif, whereas its human ortho-
logue, like pART7, carries an H-Y-L variant motif. H-Y-I
and H-Y-L variant motifs are also found in pARTs from the
slime mold (Dd.pARTg) and amoeba (Eh.pARTf) (Fig. 8).
Human pART15 carries an H-Y-Y variant motif, which is
conserved in its orthologues from mouse and the malaria
mosquito (Fig. 8). It will be interesting to determine
whether and how site directed mutagenesis of the H-Y-E
motif in pARTs 1–6 to the variant motifs of pARTs 7–17 –
and vice versa – affects their enzyme activities. Moreover,
it remains to be determined whether the most striking var-
iation of the H-Y-E motif – to Q-Y-T in human and mouse
pART9 is compatible with enzyme activity.
The results of our PSI-BLAST and PSIPRED analyses (Figs.
4, 5, 9 and additional files 3, 4, 5, 6, 7, 8) support the con-
clusions that the pART gene family described here and the
mART gene family described in our previous study [27]
constitute two distinct ART subfamilies, and further, that
the family of tRNA:NAD 2'-phosphotransferases [24,25]
constitutes a branch that is more closely related to the
pART subfamily than to the mART subfamily. Our results
illuminate the power and limits of PSI-BLAST searches:
PSI-BLAST readily connected members of the pART sub-
family in many different species, while DT, ETA and TpTs
were found at or below the threshold. In contrast PSI-
BLAST searches never connected pART family members
with members of the mART subfamily or vice versa. The
results of PSI-BLAST searches, thus, are in accord with
insights gained from the known 3D structures of repre-
sentative ADP-ribosyltransferases (Fig. 1), i.e. that certainBMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
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conserved structural features clearly distinguish these two
subfamilies. Is it possible that some of the pART gene
family members described here actually possess mono-
ADP-ribosyltransferase rather than poly-ADP-ribosyl-
transferase activity? Given the structural similarity to DT/
ETA this is a possibility. Moreover, it cannot be excluded
that some family members may have lost enzyme activity
and have acquired a new function. In any case, the respec-
tive proteins clearly are more closely related to the pART
than to the mART gene family, in line with the nomencla-
ture proposed here. Have all ARTs encoded in the human
genome been identified? A number of ADP-ribosylation
reactions have been described in mammalian cells that
cannot yet be accounted for by the ARTs identified in this
study or our previous study, e.g. mono-ADP-ribosylation
of actin, rho, glutamate dehydrogenase, and of the alpha
and beta subunits of heterotrimeric G proteins [3,4,8].
Given the fact that the pART subfamily described here and
the mART subfamily described in our previous study [27]
could not be interconnected by PSI-BLAST, it reamins an
intriguing possibility that other ART subfamilies in the
human genome still await to be identified.
Conclusion
The family of proteins containing a PARP-like catalytic
domain consists of 17 members in the human and 16 in
the mouse, rat, and pufferfish. The vertebrate pART family
can be divided into five subgroups on the basis of
sequence similarity, phylogenetic relationships, con-
served intron positions, and patterns of genetically fused
protein domains. The four members of group 1 and the
two members of group 2 each contain a conserved trias of
residues (H-Y-E motif) also observed in Diphtheria toxin
and Pseudomonas exotoxin A. The eleven other pART pro-
teins carry variants of this motif (six H-Y-I, two H-Y-L, and
one each Q-Y-T, Y-Y-V, H-Y-Y). All human pARTs are
multi-domain proteins in which the pART catalytic
domain is associated in a Lego-like fashion with other
putative protein-protein interaction, DNA binding and
ubiquitination domains. In all but one case (pART4) the
catalytic domain represents the C-terminal end of the
multi-domain protein. Most of the domain associations
observed in human pARTs appear to be very ancient
inventions since they can be found also in insects, plants,
microfungi, and amoeba.
Methods
Database searches
Protein databases were searched using PSI-BLAST [35].
Genome databases were searched using BLASTn and
tBLASTn [49]. Tissue distributions of pART-ESTs were ana-
lyzed using Electronic Northern calculations at the Gene-
Card website [50].
Structure and sequence analyses
Amino acid sequence alignments were performed with T-
Coffee [36]. Secondary structure predictions were
performed with PSIPRED [37]. Threading of amino acid
sequences onto known 3D structures in PDB were per-
formed with GenTHREADER [37]. Sequence analyses
were performed using DNA-Star software, 3D-images
were prepared with PyMol [51] software.
Phylogenetic analyses
Phylogenetic analyses were applied to the 36 catalytic core
amino acid sequences using the dataset in Figure 6. Phyl-
ogenetic analyses were performed on the computational
cluster of the College of Biology and Agriculture at
Brigham Young University by using maximum parsimony
and Bayesian Markov chain Monte Carlo approaches
http://babeast.byu.edu. The topologies were
reconstructed using equally weighted maximum parsi-
mony (MP) analysis as implemented in PAUP* 4.0b10
[52], maximum likelihood (ML) with simultaneous
adjustment of topology, and branch length as imple-
mented in PhyML [53], as well as Bayesian methods cou-
pled with Markov Chain Monte Carlo inference (BMCMC,
MrBayes) [54]. The best fit likelihood model for amino
acid evolution was determined based on the lowest
Akaike Information Criterion (AIC) or Bayesian Informa-
tion Criterion (BIC) score as implemented in ProtTest
1.2.6 [53,55,56].
The MP analysis was run using 5000 random addition
replicates and tree bisection-reconnection branch swap-
ping. Nonparametric bootstrap values were calculated for
MP and ML analyses (10.000/100 bootstrap replicates,
100/1 heuristic random addition replicates) to assess con-
fidence in the resulting relationships. ML analysis was run
implementing the RtREV+I+G+F model of amino acid
evolution (AIC= 4907.73; -lnL= 2800). The a priori infor-
mation obtained by ProtTest 1.2.6 was incorporated into
the BMCMC analysis. Bayesian phylogeny estimation was
achieved using random starting trees, run for 3 × 106 gen-
erations, with a sample frequency of 1000, and ten chains
(nine heated, temperature= 0.2). Analyses were repeated
three times to check for likelihood and parameter mixing
and congruence. Likelihood scores were plotted against
generation time to determine stationery levels. Sample
points before reaching stationery were discarded as "burn-
in". Repeated analyses were compared for convergence on
the same posterior probability distributions [57]. The
maximum  a posteriori tree (MAP) is presented in this
paper, showing to percentage converted posterior proba-
bilities (pP%).
Abbreviations used
ART = ADP-Ribosyltransferase, BLAST = basic local align-
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nicotinamide adenine dinucleotide, PDB = protein
database.
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Additional File 1
Representation of pART gene transcripts in the database of expressed 
sequence tags The public EST database was screened for ESTs encoding 
pARTs using tBLASTn and the amino acid sequences of the catalytic 
domain of known pART family members as queries at the dates indicated 
on top. Accession numbers of the corresponding Unigene clusters are indi-
cated. Blank fields indicate lack of detectable ESTs encoding the respective 
pART catalytic domain. Tissue distribution analyses were performed for 
each cluster by "electronic Northern" analyses. For each family member, 
the two tissues with the highest numbers of ESTs are indicated. Tissue 
abbreviations: BMR bone marrow, BRN brain, HRT heart, MSL muscle, 
PNC pancreas, PST prostate, KDN kidney, LNG lung, LVR liver, LYN 
lymph node, SPC spinal chord, SPL spleen, TMS thymus, UTR uterus
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-6-139-S1.pdf]
Additional File 2
Schematic illustration of the local human and mouse chromosomal 
environments of the pART subgroup 3 gene cluster The figure schemat-
ically illustrates the local chromosomal environment of the syntenic cluster 
of pART genes and neighboring genes on human chromosome 3q (top) 
and mouse chromosome 16B3 (bottom). The order and orientation of all 
genes in the depicted cluster is conserved. Known transcripts in GenBank 
are indicated schematically with their respective accession number. Exons 
are indicated by boxes. The direction of transcription is marked by arrows. 
Grey vertical bars correspond to a scale of 10.000 base pairs. The figure 
was modified from the respective online UCSC human and mouse genome 
browsers http://genome.ucsc.edu.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-6-139-S2.pdf]
Additional File 3
Multiple amino acid sequence alignments, secondary structure predic-
tions, and threading results for pART subgroup 1 A multiple sequence 
alignment was generated for the catalytic domains of pARTs 1–4 with T-
Coffee. Each residue in the sequence is reported as a single letter code. Sec-
ondary structure units in the 3D structures of chicken PARP-1 (1a26) 
and mouse PARP-2 (1GS0) are indicated on top of the alignment. Posi-
tions with identical residues in all sequences are marked by asterisks, sim-
ilarities are marked with colons and periods below the alignment. Residues 
corresponding to the H Y E motif in the NAD binding crevice of diphtheria 
toxin are marked in red. Intron positions are projected onto the multiple 
alignment and are marked in grey (phase 0), blue (phase 1), and yellow 
(phase 2). Secondary structure predictions were generated for human 
pART1 with PSIPRED and are indicated in blue below the alignment 
(pr1); the confidence of the prediction is indicated in orange (highest con-
fidence = 9). Secondary structure units are abbreviated as follows: H = 
helix; B = residue in isolated beta bridge; E = extended beta strand; G = 
310 helix; I = pi helix; T = hydrogen bonded turn; S = bend.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-6-139-S3.pdf]
Additional File 4
Multiple amino acid sequence alignments, secondary structure predic-
tions, and threading results for pART subgroup 2 A multiple sequence 
alignment was generated for the catalytic domains of pARTs 5 and 6 with 
T-Coffee. Residues, identities, intron positions, and secondary structure 
units are marked as in additional file 3. Indicated secondary structure pre-
dictions were generated for human pART5 (pr5) with PSIPRED.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-6-139-S4.pdf]
Additional File 5
Multiple amino acid sequence alignments, secondary structure predic-
tions, and threading results for pART subgroup 3 A multiple sequence 
alignment was generated for the catalytic domains of pARTs 7–10 with T-
Coffee. Residues, identities, intron positions, and secondary structure 
units are marked as in additional file 3. Indicated secondary structure pre-
dictions were generated for human pART7 (pr7) with PSIPRED.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-6-139-S5.pdf]
Additional File 6
Multiple amino acid sequence alignments, secondary structure predic-
tions, and threading results for pART subgroup 4 A multiple sequence 
alignment was generated for the catalytic domains of pARTs 11–14 with 
T-Coffee. Residues, identities, intron positions, and secondary structure 
units are marked as in additional file 3. Indicated secondary structure pre-
dictions were generated for human pART11 (pr11) with PSIPRED.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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Representative tiling paths of PSI-BLAST searches initiated with the 
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cated on top at a threshold setting for the expect value of 0.005 as in 
Figure 4. pART subgroups are color coded as in Figure 2. Matching 
sequences from the slime mold (D. discoideum, blue) and from a model 
plant (A. thaliana, green) are indicated at the iteration in which they first 
appeared above threshold. The respective pART homologues from these 
species were arbitrarily numbered (pARTa-j) in the order in which they 
were detected in the search that was initiated with human pART1 (PARP-
1). Protein data base accession numbers are listed in Figure 9. pARTs 
indicated in black include short possibly truncated coding sequences of 
pART homologues that could not be assigned to a particular subgroup with 
certainty.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-6-139-S8.pdf]BMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
Page 22 of 23
(page number not for citation purposes)
Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin
R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt
A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S,
Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S,
Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA,
Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL,
Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB,
Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T,
Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett
N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M,
Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley
KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS,
Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T,
Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T,
Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T,
Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L,
Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer
M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G,
Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA,
Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood
J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S,
Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser
J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia
N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bai-
ley JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge
CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T,
Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hay-
ashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS,
Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin
EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T,
Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J,
Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-
Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe
KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A,
Wetterstrand KA, Patrinos A, Morgan MJ, Szustakowki J, de Jong P,
Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ: Initial
sequencing and analysis of the human genome.  Nature 2001,
409:860-921.
29. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal
P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE,
Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B,
Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown
SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S,
Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins
FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V,
Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitza-
kis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn
DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A,
Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey
TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt
L, Grafham D, Graves TA, Green ED, Gregory S, Guigo R, Guyer M,
Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A,
Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I,
Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK,
Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, Kent WJ, Kirby
A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T,
Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S,
Ma B, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH,
McCarthy M, McCombie WR, McLaren S, McLay K, McPherson JD,
Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E,
Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash
WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor
MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin
KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC,
Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM,
Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J,
Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T,
Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith
DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M,
Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C,
Ureta-Vidal A, Vinson JP, Von Niederhausern AC, Wade CM, Wall M,
Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K,
Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson
RK, Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM,
Zody MC, Lander ES: Initial sequencing and comparative anal-
ysis of the mouse genome.  Nature 2002, 420:520-562.
30. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ,
Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G,
Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G,
Morgan M, Hawes A, Gill R, Celera, Holt RA, Adams MD, Amanatides
PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fos-
ler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch
CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM,
Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K,
Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard
GG, De Jong PJ, Osoegawa K, Zhu B, Marra M, Schein J, Bosdet I, Fjell
C, Jones S, Krzywinski M, Mathewson C, Siddiqui A, Wye N, McPher-
son J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y,
Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A,
Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Cooney AJ, D'Souza
LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ,
McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang
Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A,
Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexan-
dersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S,
Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar
Alba M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O,
Poliakov A, Hubner N, Ganten D, Goesele C, Hummel O, Kreitler T,
Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H,
Jacob HJ, Bromberg S, Gullings-Handley J, Jensen-Seaman MI, Kwitek
AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM,
Rice S, Goodstadt L, Beatson SA, Emes RD, Winter EE, Webber C,
Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara
P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko
A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K,
Andrews TD, Caccamo M, Clamp M, Clarke L, Curwen V, Durbin R,
Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A,
Stone EA, Payseur BA, Bourque G, Lopez-Otin C, Puente XS, Chakra-
barti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A,
Tesler G, Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson
H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR,
Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent
M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H,
Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S,
Collins F: Genome sequence of the Brown Norway rat yields
insights into mammalian evolution.  Nature 2004, 428:493-521.
31. Takeyama K, Aguiar RC, Gu L, He C, Freeman GJ, Kutok JL, Aster JC,
Shipp MA: The BAL-binding protein BBAP and related Deltex
family members exhibit ubiquitin-protein isopeptide ligase
activity.  J Biol Chem 2003, 278:21930-21937.
32. Yu M, Schreek S, Cerni C, Schamberger C, Lesniewicz K, Poreba E,
Vervoorts J, Walsemann G, Grotzinger J, Kremmer E, Mehraein Y,
Mertsching J, Kraft R, Austen M, Luscher-Firzlaff J, Luscher B: PARP-
10, a novel Myc-interacting protein with poly(ADP-ribose)
polymerase activity, inhibits transformation.  Oncogene 2005.
33. Gao G, Guo X, Goff SP: Inhibition of retroviral RNA production
by ZAP, a CCCH-type zinc finger protein.  Science 2002,
297:1703-1706.
34. Ma Q, Baldwin KT, Renzelli AJ, McDaniel A, Dong L: TCDD-induc-
ible poly(ADP-ribose) polymerase: a novel response to
2,3,7,8-tetrachlorodibenzo-p-dioxin.  Biochem Biophys Res
Commun 2001, 289:499-506.
35. Altschul SF, Koonin EV: Iterated profile searches with PSI-
BLAST--a tool for discovery in protein databases.  Trends Bio-
chem Sci 1998, 23:444-447.
36. Notredame C, Higgins DG, Heringa J: T-Coffee: A novel method
for fast and accurate multiple sequence alignment.  J Mol Biol
2000, 302:205-217.
37. McGuffin LJ, Bryson K, Jones DT: The PSIPRED protein struc-
ture prediction server.  Bioinformatics 2000, 16:404-405.
38. Koch-Nolte F, Reche P, Haag F, Bazan F: ADP-ribosyltransferases:
plastic tools for inactivating protein and small molecular
weight targets.  J Biotechnol 2001, 92:81-87.
39. Han S, Tainer JA: The ARTT motif and a unified structural
understanding of substrate recognition in ADP-ribosylating
bacterial toxins and eukaryotic ADP-ribosyltransferases.  Int
J Med Microbiol 2002, 291:523-529.
40. Sun J, Maresso AW, Kim JJ, Barbieri JT: How bacterial ADP-ribo-
sylating toxins recognize substrates.  Nat Struct Mol Biol 2004,
11:868-876.
41. Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, Pontius
JU, Schuler GD, Schriml LM, Sequeira E, Tatusova TA, Wagner L:Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2005, 6:139 http://www.biomedcentral.com/1471-2164/6/139
Page 23 of 23
(page number not for citation purposes)
Database resources of the National Center for
Biotechnology.  Nucleic Acids Res 2003, 31:28-33.
42. Ladurner AG: Inactivating chromosomes: a macro domain
that minimizes transcription.  Mol Cell 2003, 12:1-3.
43. Jaillon O, Aury JM, Brunet F, Petit JL, Stange-Thomann N, Mauceli E,
Bouneau L, Fischer C, Ozouf-Costaz C, Bernot A, Nicaud S, Jaffe D,
Fisher S, Lutfalla G, Dossat C, Segurens B, Dasilva C, Salanoubat M,
Levy M, Boudet N, Castellano S, Anthouard V, Jubin C, Castelli V,
Katinka M, Vacherie B, Biemont C, Skalli Z, Cattolico L, Poulain J, De
Berardinis V, Cruaud C, Duprat S, Brottier P, Coutanceau JP, Gouzy
J, Parra G, Lardier G, Chapple C, McKernan KJ, McEwan P, Bosak S,
Kellis M, Volff JN, Guigo R, Zody MC, Mesirov J, Lindblad-Toh K, Bir-
ren B, Nusbaum C, Kahn D, Robinson-Rechavi M, Laudet V, Schachter
V, Quetier F, Saurin W, Scarpelli C, Wincker P, Lander ES, Weissen-
bach J, Roest Crollius H: Genome duplication in the teleost fish
Tetraodon nigroviridis reveals the early vertebrate proto-
karyotype.  Nature 2004, 431:946-957.
44. Hillier LW, Miller W, Birney E, Warren W, Hardison RC, Ponting CP,
Bork P, Burt DW, Groenen MA, Delany ME, Dodgson JB, Chinwalla
AT, Cliften PF, Clifton SW, Delehaunty KD, Fronick C, Fulton RS,
Graves TA, Kremitzki C, Layman D, Magrini V, McPherson JD, Miner
TL, Minx P, Nash WE, Nhan MN, Nelson JO, Oddy LG, Pohl CS, Ran-
dall-Maher J, Smith SM, Wallis JW, Yang SP, Romanov MN, Rondelli
CM, Paton B, Smith J, Morrice D, Daniels L, Tempest HG, Robertson
L, Masabanda JS, Griffin DK, Vignal A, Fillon V, Jacobbson L, Kerje S,
Andersson L, Crooijmans RP, Aerts J, van der Poel JJ, Ellegren H,
Caldwell RB, Hubbard SJ, Grafham DV, Kierzek AM, McLaren SR,
Overton IM, Arakawa H, Beattie KJ, Bezzubov Y, Boardman PE, Bon-
field JK, Croning MD, Davies RM, Francis MD, Humphray SJ, Scott CE,
Taylor RG, Tickle C, Brown WR, Rogers J, Buerstedde JM, Wilson
SA, Stubbs L, Ovcharenko I, Gordon L, Lucas S, Miller MM, Inoko H,
Shiina T, Kaufman J, Salomonsen J, Skjoedt K, Wong GK, Wang J, Liu
B, Yu J, Yang H, Nefedov M, Koriabine M, Dejong PJ, Goodstadt L,
Webber C, Dickens NJ, Letunic I, Suyama M, Torrents D, von Mering
C, Zdobnov EM, Makova K, Nekrutenko A, Elnitski L, Eswara P, King
DC, Yang S, Tyekucheva S, Radakrishnan A, Harris RS, Chiaromonte
F, Taylor J, He J, Rijnkels M, Griffiths-Jones S, Ureta-Vidal A, Hoffman
MM, Severin J, Searle SM, Law AS, Speed D, Waddington D, Cheng Z,
Tuzun E, Eichler E, Bao Z, Flicek P, Shteynberg DD, Brent MR, Bye JM,
Huckle EJ, Chatterji S, Dewey C, Pachter L, Kouranov A, Mourelatos
Z, Hatzigeorgiou AG, Paterson AH, Ivarie R, Brandstrom M, Axelsson
E, Backstrom N, Berlin S, Webster MT, Pourquie O, Reymond A, Ucla
C, Antonarakis SE, Long M, Emerson JJ, Betran E, Dupanloup I, Kaess-
mann H, Hinrichs AS, Bejerano G, Furey TS, Harte RA, Raney B,
Siepel A, Kent WJ, Haussler D, Eyras E, Castelo R, Abril JF, Castellano
S, Camara F, Parra G, Guigo R, Bourque G, Tesler G, Pevzner PA,
Smit A, Fulton LA, Mardis ER, Wilson RK: Sequence and compar-
ative analysis of the chicken genome provide unique per-
spectives on vertebrate evolution.  Nature 2004, 432:695-716.
45. Seimiya H, Smith S: The telomeric poly(ADP-ribose) polymer-
ase, tankyrase 1, contains multiple binding sites for telom-
eric repeat binding factor 1 (TRF1) and a novel acceptor,
182-kDa tankyrase-binding protein (TAB182).  J Biol Chem
2002, 277:14116-14126.
46. Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli
M, Rome LH: The 193-kD vault protein, VPARP, is a novel
poly(ADP-ribose) polymerase.  J Cell Biol 1999, 146:917-928.
47. Chang W, Dynek JN, Smith S: TRF1 is degraded by ubiquitin-
mediated proteolysis after release from telomeres.  Genes Dev
2003, 17:1328-1333.
48. Jakob NJ, Darai G: Molecular anatomy of chilo iridescent virus
genome and the evolution of viral genes.  Virus Genes 2002,
25:299-316.
49. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local
alignment search tool.  J Mol Biol 1990, 215:403-410.
50. Rebhan M, Chalifa-Caspi V, Prilusky JLD: GeneCards: encyclope-
dia for genes, proteins and diseases.   [http://bioinformatics.weiz
mann.ac.il/cards].
51. DeLano WL: The PyMOL User's Manual.  2002 [http://
www.pymol.org]. San Carlos, CA, USA., DeLano Scientific
52. Swofford DL: PAUP: Phylogenetic Analysis Using Parsimony
(and other methods) version 4.  Sunderland, Massachusetts, Sin-
auer Associates Inc.; 2002. 
53. Guindon S, Gascuel O: A simple, fast, and accurate algorithm
to estimate large phylogenies by maximum likelihood.  Syst
Biol 2003, 52:696-704.
54. Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic
inference under mixed models.  Bioinformatics 2003,
19:1572-1574.
55. Drummond A, Strimmer K: PAL: an object-oriented program-
ming library for molecular evolution and phylogenetics.  Bio-
informatics 2001, 17:662-663.
56. Abascal F, Zardoya R, Posada D: Prottest: selection of best-fit
models of protein evolution.  Bioinformatics 2005.
57. Huelsenbeck JP, Bollback JP: Empirical and hierarchical Bayesian
estimation of ancestral states.  Syst Biol 2001, 50:351-366.